Canary Foundation envisions a world of simple tests that identify and isolate cancer at its earliest most curable stage. The goal of our cancer programs is to develop early detection screening strategies, consisting of blood tests and molecular imaging techniques, that will allow us to detect lethal cancers early enough to be curable. Several of Canary Foundation's science teams have made considerable progress toward this goal. Now, they are moving their discoveries into cancer diagnostics clinical trials, where they can begin to benefit patients.

Canary Foundation supports clinical trials in both areas — blood tests and molecular imaging diagnostics — for ovarian cancer, prostate cancer, and lung cancer.